as on November 13, 2025 at 1:38 am IST
Day's Low
Day's High
2.55%
Downside
2.93%
Upside
52 Week's Low
52 Week's High
87.84%
Downside
12.13%
Upside
Check Cidara Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.3B
EPS (TTM)
-8.7867
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.8
Industry PE ratio
0PEG Ratio
0EBITDA
-159.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-68.70%
Track how Cidara Therapeutics Inc P/E has moved over time to understand its valuation trends.
Cidara Therapeutics Inc in the last 5 years
Lowest (-180.77x)
June 30, 2023
Industry (0.00x)
November 12, 2025
Today (-0.80x)
November 12, 2025
Highest (-0.48x)
September 30, 2024
Today’s Price to Earnings Ratio: -0.80x
Compare market cap, revenue, PE, and other key metrics of Cidara Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.3B | 114.66% | -0.8 | 0.00% | |
| BUY | $41.3B | 426.19% | -16.34 | -264.83% | |
| BUY | $58.4B | 241.25% | 1424.84 | 1.36% | |
| BUY | $106.9B | 96.61% | 29.68 | 31.35% | |
| BUY | $68.8B | 21.15% | 15.7 | 32.13% |
The Cidara Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cidara Therapeutics Inc investment value today
Current value as on today
₹8,08,815
Returns
₹7,08,815
(+708.81%)
Returns from Cidara Therapeutics Inc Stock
₹7,03,717 (+703.72%)
Dollar Returns*
₹5,097 (+5.1%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Cidara Therapeutics Inc. Average target price of $160.71
Get share price movements and forecasts by analysts on Cidara Therapeutics Inc.
What analysts predicted
32.74%UPSIDE
Target Price
$160.71
Current Price
$108.1
Analyzed by
10 Analysts
Target
$160.71
Cidara Therapeutics Inc target price $160.71, a slight upside of 32.74% compared to current price of $108.1. According to 10 analysts rating.
Search interest for Cidara Therapeutics Inc Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, CDTX has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 6 months, CDTX stock has moved up by 456.8%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 915.7% return, outperforming this stock by 32.2%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 17.58M → 302.0K (in $), with an average decrease of 74.2% per quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, -23.48M → -83.23M (in $), with an average decrease of 116.6% per quarter
| Organisation | Cidara Therapeutics Inc |
| Headquarters | 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Dr. Jeffrey L. Stein Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Kevin M. Forrest Ph.D. | Founder & Chief Strategy Officer |
Mr. Frank L. Karbe M.B.A. | Chief Financial Officer |
Ms. Allison Lewis CCP, SPHR | Senior Vice President of People & Culture |
Mr. Jim Beitel M.B.A. | Chief Business Officer |
Dr. Jeffrey L. Stein Ph.D. | President, CEO & Executive Director |
Dr. Leslie Tari Ph.D. | Chief Scientific Officer |
Dr. Nicole Davarpanah J.D., M.D. | Chief Medical Officer |
Ms. Corrina Pavetto | Senior Vice President of Clinical Development |
Mr. Shane M. Ward J.D. | COO & Corporate Secretary |
Dr. Preetam Shah M.B.A., Ph.D. | Principal Accounting Officer |
Cidara Therapeutics Inc share price today is $108.1 as on . Cidara Therapeutics Inc share today touched a day high of $111.27 and a low of $105.34.
Cidara Therapeutics Inc share touched a 52 week high of $121.21 on and a 52 week low of $13.14 on . Cidara Therapeutics Inc stock price today i.e. is trending at $108.1,which is 10.82% down from its 52 week high and 722.68% up from its 52 week low.
Cidara Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Cidara Therapeutics Inc (CDTX) shares with as little as ₹88.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.18 in Cidara Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cidara Therapeutics Inc share’s latest price of $108.1 as on November 13, 2025 at 1:38 am IST, you will get 0.0925 shares of Cidara Therapeutics Inc. Learn more about
fractional shares .
Cidara Therapeutics Inc stock has given 114.66% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?